日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

eIF4A 控制雌激素受体 α 的翻译,是晚期乳腺癌的治疗靶点

Boyer Jacob A, Rosen Ezra Y, Sharma Malvika, Dorso Madeline A, Mai Nicholas, Amor Corina, Reiter Jason M, Kannan Ram, Gadal Sunyana, Xu Jianing, Miele Matthew, Li Zhuoning, Chen Xiaoping, Chang Qing, Pareja Fresia, Worland Stephan, Warner Douglas, Sperry Sam, Chiang Gary G, Thompson Peggy A, Yang Guangli, Ouerfelli Ouathek, Drilon Alexander, de Stanchina Elisa, Wendel Hans-Guido, Chandarlapaty Sarat, Rosen Neal

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma

靶向赖氨酸去甲基化酶 5 (KDM5) 治疗套细胞淋巴瘤

Xu, Danmei; Bewicke-Copley, Findlay; Close, Karina; Okosun, Jessica; Gale, Robert Peter; Apperley, Jane; Weinstock, David M; Wendel, Hans-Guido; Fitzgibbon, Jude

Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines

新获得的HGBL双/三重打击淋巴瘤细胞系的遗传特征和药物敏感性研究

Zhang, Jibin; Wang, Tingting; Shetty, Kunal; Alkan, Serhan; Xu, Senlin; Gong, Qiang; Liu, Xuxiang; Li, Yuping; Hu, Zunsong; Huang, Wendong; Wendel, Hans-Guido; Herrera, Alex F; Pillai, Raju K; Song, Joo Y; Chan, Wing C

Genomic studies indicate a novel combination therapy for follicular lymphoma

基因组研究表明,滤泡性淋巴瘤可能存在一种新的联合疗法。

Oricchio, Elisa; Wendel, Hans-Guido

O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

O-GlcNAcase靶向丙酮酸激酶M2以调节肿瘤生长

Singh, Jay Prakash; Qian, Kevin; Lee, Jeong-Sang; Zhou, Jinfeng; Han, Xuemei; Zhang, Bichen; Ong, Qunxiang; Ni, Weiming; Jiang, Mingzuo; Ruan, Hai-Bin; Li, Min-Dian; Zhang, Kaisi; Ding, Zhaobing; Lee, Philip; Singh, Kamini; Wu, Jing; Herzog, Raimund I; Kaech, Susan; Wendel, Hans-Guido; Yates, John R 3rd; Han, Weiping; Sherwin, Robert S; Nie, Yongzhan; Yang, Xiaoyong

Emerging epigenetic-modulating therapies in lymphoma

淋巴瘤中新兴的表观遗传调控疗法

Sermer, David; Pasqualucci, Laura; Wendel, Hans-Guido; Melnick, Ari; Younes, Anas

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

B细胞急性淋巴细胞白血病患者CAR-T细胞疗法相关神经毒性的临床和生物学相关性

Santomasso, Bianca D; Park, Jae H; Salloum, Darin; Riviere, Isabelle; Flynn, Jessica; Mead, Elena; Halton, Elizabeth; Wang, Xiuyan; Senechal, Brigitte; Purdon, Terence; Cross, Justin R; Liu, Hui; Vachha, Behroze; Chen, Xi; DeAngelis, Lisa M; Li, Daniel; Bernal, Yvette; Gonen, Mithat; Wendel, Hans-Guido; Sadelain, Michel; Brentjens, Renier J

Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations

帕比司他与伊布替尼对具有MyD88 L265P突变的弥漫性大B细胞淋巴瘤细胞具有协同作用。

Mondello, Patrizia; Brea, Elliott J; De Stanchina, Elisa; Toska, Eneda; Chang, Aaron Y; Fennell, Myles; Seshan, Venkatraman; Garippa, Ralph; Scheinberg, David A; Baselga, José; Wendel, Hans-Guido; Younes, Anas

Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma

SESTRIN1 的遗传和表观遗传失活控制滤泡性淋巴瘤中的 mTORC1 和对 EZH2 抑制的反应

Oricchio, Elisa; Katanayeva, Natalya; Donaldson, Maria Christine; Sungalee, Stephanie; Pasion, Joyce P; Béguelin, Wendy; Battistello, Elena; Sanghvi, Viraj R; Jiang, Man; Jiang, Yanwen; Teater, Matt; Parmigiani, Anita; Budanov, Andrei V; Chan, Fong Chun; Shah, Sohrab P; Kridel, Robert; Melnick, Ari M; Ciriello, Giovanni; Wendel, Hans-Guido

RiboDiff: detecting changes of mRNA translation efficiency from ribosome footprints

RiboDiff:通过核糖体足迹检测mRNA翻译效率的变化

Zhong, Yi; Karaletsos, Theofanis; Drewe, Philipp; Sreedharan, Vipin T; Kuo, David; Singh, Kamini; Wendel, Hans-Guido; Rätsch, Gunnar